Recruiting Neurofibromatosis Studies in Rochester
About Neurofibromatosis Clinical Trials in Rochester
Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerve tissue. NF1 is the most common type, causing skin changes and bone deformities. Treatment includes monitoring, surgery for problematic tumors, and MEK inhibitors for plexiform neurofibromas.
There are currently 1 neurofibromatosis clinical trials recruiting participants in Rochester, MINNESOTA. These studies are seeking a combined 92 participants. Research is being sponsored by Recursion Pharmaceuticals Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neurofibromatosis Clinical Trials in Rochester — FAQ
Are there neurofibromatosis clinical trials in Rochester?
Yes, there are 1 neurofibromatosis clinical trials currently recruiting in Rochester, MINNESOTA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Rochester?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.
Are clinical trials in Rochester free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.
What neurofibromatosis treatments are being tested?
The 1 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for neurofibromatosis.
Data updated March 2, 2026 from ClinicalTrials.gov